Vicarious Surgical Inc. (RBOT)
USD 12.46
(-10.1%)
USD 12.46
(-10.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 1.85 Million | 1.94 Million | 316 Thousand | - | - |
| Gross Profit | -1.85 Million | -1.94 Million | -316 Thousand | - | - |
| Operating Expenses | 80.66 Million | 80.07 Million | 38.57 Million | 12.98 Million | 9.78 Million |
| Selling, General and Administrative Expenses | 33.08 Million | 36.17 Million | 16.47 Million | 3.18 Million | 2.3 Million |
| Research and Development Expenses | 47.57 Million | 43.9 Million | 22.1 Million | 9.79 Million | 7.47 Million |
| Other Expenses | - | - | - | - | - |
| Cost and Expenses | 80.66 Million | 80.07 Million | 38.57 Million | 12.98 Million | 9.78 Million |
| Operating Income | -80.66 Million | -80.07 Million | -38.57 Million | -12.98 Million | -9.78 Million |
| Interest Expense | 25 Thousand | 200 Thousand | 89 Thousand | 3000.00 | - |
| Income Tax Expense | - | -84 Million | -227 Thousand | 3000.00 | -67.86 Thousand |
| Earnings before Tax | -71.07 Million | 5.15 Million | -7.26 Million | -12.87 Million | -9.31 Million |
| Net Income | -71.07 Million | 89.15 Million | -7.04 Million | -12.87 Million | -9.31 Million |
| Earnings Per Share Basic | -0.49 | 20.77 | -2.19 | -4.91 | -1.70 |
| Earnings Per Share Diluted | -0.49 | 20.99 | -2.19 | -4.91 | -1.70 |
| Weighted Average Shares Outstanding | 146 Million | 4.29 Million | 3.21 Million | 2.62 Million | 5.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 146 Million | 4.24 Million | 3.21 Million | 2.62 Million | 5.46 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -69.19 Million | 7.29 Million | -34.8 Million | -161.17 Thousand | -9.67 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 3.45 Million | - | - | - |
| Cost of Revenue | 524 Thousand | 521 Thousand | 525 Thousand | 1.85 Million | 447 Thousand | 641 Thousand |
| Gross Profit | -524 Thousand | -521 Thousand | 2.92 Million | -1.85 Million | -447 Thousand | -641 Thousand |
| Operating Expenses | 17.18 Million | 15.58 Million | 15.01 Million | 78.81 Million | 21.35 Million | 21.45 Million |
| Selling, General and Administrative Expenses | 6.78 Million | 6.14 Million | 7.07 Million | - | 8.31 Million | 8.74 Million |
| Research and Development Expenses | 10.4 Million | 9.44 Million | 7.94 Million | - | 13.04 Million | 12.71 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 17.71 Million | 16.1 Million | 15.54 Million | 80.66 Million | 21.35 Million | 21.45 Million |
| Operating Income | -17.71 Million | -16.1 Million | -15.54 Million | -80.66 Million | -21.35 Million | -21.45 Million |
| Interest Expense | - | - | 22 Thousand | 25 Thousand | -1000.00 | 1000.00 |
| Income Tax Expense | -1.00 | 477.72 Thousand | -4.14 Million | -1.00 | -447 Thousand | -1.04 Million |
| Earnings before Tax | -15.2 Million | -17 Million | -13.11 Million | -71.07 Million | -15.7 Million | -15.33 Million |
| Net Income | -15.2 Million | -17 Million | -13.11 Million | -71.07 Million | -15.7 Million | -15.33 Million |
| Earnings Per Share Basic | -2.59 | -2.91 | -2.25 | - | -3.04 | -3.63 |
| Earnings Per Share Diluted | -2.59 | -2.91 | -2.25 | - | -3.04 | -3.63 |
| Weighted Average Shares Outstanding | 5.87 Million | 5.85 Million | 5.83 Million | 4.86 Million | 5.16 Million | 4.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.87 Million | 5.85 Million | 5.83 Million | 4.86 Million | 5.16 Million | 4.22 Million |
| Gross Margin | - | - | 0.85 | - | - | - |
| EBIT Margin | - | - | -4.35 | - | - | - |
| Profit Margin | - | - | -3.80 | - | - | - |
| EBITDA | -17.18 Million | -15.58 Million | -15.01 Million | - | -21.35 Million | -20.41 Million |
| Earnings Before Tax Margin | - | - | -4.50 | - | - | - |
NEAGI
8278
002494
REAL
CHPT
GOMRF